Erasca, Inc. (ERAS)
14.14
-0.16
(-1.12%)
USD |
NASDAQ |
Oct 07, 16:00
14.14
0.00 (0.00%)
After-Hours: 18:44
Erasca Net Income (Quarterly) : -44.08M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -44.08M |
| March 31, 2026 | -183.44M |
| December 31, 2025 | -29.09M |
| September 30, 2025 | -30.61M |
| June 30, 2025 | -33.88M |
| March 31, 2025 | -30.97M |
| December 31, 2024 | -32.23M |
| September 30, 2024 | -31.20M |
| June 30, 2024 | -63.20M |
| March 31, 2024 | -35.02M |
| December 31, 2023 | -29.70M |
| September 30, 2023 | -30.36M |
| June 30, 2023 | -31.78M |
| Date | Value |
|---|---|
| March 31, 2023 | -33.20M |
| December 31, 2022 | -135.25M |
| September 30, 2022 | -35.49M |
| June 30, 2022 | -35.61M |
| March 31, 2022 | -36.46M |
| December 31, 2021 | -30.46M |
| September 30, 2021 | -46.07M |
| June 30, 2021 | -28.21M |
| March 31, 2021 | -18.02M |
| December 31, 2020 | -61.90M |
| September 30, 2020 | -10.61M |
| June 30, 2020 | -5.491M |
| March 31, 2020 | -23.66M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -178.92M |
| Twist Bioscience Corp. | -35.05M |
| Immunome, Inc. | -73.13M |
| Oncolytics Biotech, Inc. | -9.442M |
| Sangamo Therapeutics, Inc. | -31.00M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 44.08M |
| EPS Diluted (Quarterly) | -0.1416 |
| Enterprise Value | 4.246B |
| Earnings Yield | -6.75% |
| Normalized Earnings Yield | -4.277 |